Glycomine rakes in $33 mln Series B
San Carlos, California-based Glycomine Inc, a biotechnology company, has raised $33 million in Series B financing. Novo Holdings A/S led the round.
7 August 2019•1 min read
San Carlos, California-based Glycomine Inc, a biotechnology company, has raised $33 million in Series B financing. Novo Holdings A/S led the round.
